Kids & teens (for parents) · Oregon
Studies for children and teens in Oregon
These studies only enroll people under 18. A parent or legal guardian gives permission, and children old enough to understand are asked for their own agreement (assent).
24 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 3
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
Pfizer
- Location
- Gresham, OR + 20 other US sites
- Eligibility basics
- Ages 1 mo–4 mo
- RecruitingHealthy volunteersPhase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
GlaxoSmithKline
- Location
- Gresham, OR + 46 other US sites
- Eligibility basics
- Ages 1–1
- RecruitingPhase 1/Phase 2
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Encoded Therapeutics
- Location
- Portland, OR + 9 other US sites
- Eligibility basics
- Ages 6 mo–17
- RecruitingPhase 3
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Pfizer
- Location
- Portland, OR + 18 other US sites
- Eligibility basics
- Ages 6–14
- RecruitingPhase 1
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
Novartis Pharmaceuticals
- Location
- Portland, OR + 10 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
Axsome Therapeutics, Inc.
- Location
- Portland, OR + 28 other US sites
- Eligibility basics
- Ages 6–11
- RecruitingPhase 2
This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent…
Bausch Health Americas, Inc.
- Location
- Gresham, OR + 22 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 4
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Supernus Pharmaceuticals, Inc.
- Location
- Gresham, OR + 38 other US sites
- Eligibility basics
- Ages 4–5
- RecruitingPhase 3
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
AstraZeneca
- Location
- Portland, OR + 18 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Pfizer
- Location
- Portland, OR + 69 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Pfizer
- Location
- Portland, OR + 54 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active…
AbbVie
- Location
- Portland, OR + 4 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
AbbVie
- Location
- Portland, OR + 87 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company
- Location
- Portland, OR + 28 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 1/Phase 2
Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators
Astellas Gene Therapies
- Location
- Portland, OR + 3 other US sites
- Eligibility basics
- Up to age 3 · Men only
- RecruitingPhase 4
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
Bausch Health Americas, Inc.
- Location
- Gresham, OR + 9 other US sites
- Eligibility basics
- Ages 6–12
- RecruitingPhase 4
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
Bausch Health Americas, Inc.
- Location
- Gresham, OR + 13 other US sites
- Eligibility basics
- Ages 9–11
- RecruitingPhase 1/Phase 2
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
Solid Biosciences Inc.
- Location
- Portland, OR + 11 other US sites
- Eligibility basics
- Ages 0 mo–17 · Men only
- RecruitingPhase 3
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
LEO Pharma
- Location
- Portland, OR + 13 other US sites
- Eligibility basics
- Ages 6 mo–11
- RecruitingPhase 4
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Upsher-Smith Laboratories
- Location
- Portland, OR + 5 other US sites
- Eligibility basics
- Ages 6–11
- RecruitingHealthy volunteers
Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)
University of Oregon
- Location
- Salem, OR + 2 other US sites
- Eligibility basics
- Ages 8–15
- RecruitingHealthy volunteers
RISE Lab: Building Resilience Through Responsibility
University of Oregon
- Location
- Eugene, OR
- Eligibility basics
- Ages 11–14
- RecruitingHealthy volunteers
Adaptation of the Family Check-Up Online
University of Oregon
- Location
- Eugene, OR
- Eligibility basics
- Ages 11–14
- RecruitingHealthy volunteers
Clinical and Genetic Analysis of ROP
Oregon Health and Science University
- Location
- Portland, OR + 2 other US sites
- Eligibility basics
- Up to age 1